“Despite slightly diminished effectiveness, the Pfizer vaccine most likely protects” versus the alternative discovered in India, according to lab test results, said Olivier Schwartz, the institutes director and co-author of the study that was released on the BioRxiv site ahead of peer review. People who had gotten two dosages of Pfizer saw a three-fold reduction in their antibodies versus the variant, B. 1.617, according to the research study, however were still secured. Clients who had had Covid-19 within the previous year and people vaccinated with two doses of Pfizer retained enough antibodies to be secured against the variant found in India, but three to six times less antibodies than against the UK variant, Schwartz said.
- Covid-19 vaccine in the US live updates: CDC investigating potential heart problems, vaccination lottery… – AS English
- Coronavirus vaccines may be slightly less effective for women than men, emerging research suggests – Business Insider